Eskinder H, Hillard C J, Olinger G N, Christensen C W, Baker J E, Warltier D C, Gross G J
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee.
J Pharmacol Exp Ther. 1988 Dec;247(3):941-8.
The purpose of this investigation was to determine the subtypes of alpha adrenoceptors present in human saphenous vein and to determine if there is a large receptor reserve for phenylephrine as has been demonstrated in canine saphenous vein. The subtypes of alpha adrenoceptors found in isolated human saphenous vein were determined using selective alpha-1 and alpha-2 adrenoceptor agonists and antagonists. Prazosin, a selective alpha-1 antagonist, produced a parallel shift of the concentration response curve to phenylephrine, a selective alpha-1 agonist, with no significant reduction in the maximal response. Yohimbine, a selective alpha-2 antagonist, produced a parallel shift of the concentration response curve to B-HT 920, a selective alpha-2 agonist, with no reduction in the maximal response. The pA2 values obtained for prazosin and yohimbine in human saphenous vein agreed closely with corresponding values obtained in canine saphenous vein. These results demonstrate that both alpha-1 and alpha-2 adrenoceptors exist in human saphenous vein. Phenoxybenzamine (10(-7) M), an irreversible alpha-1 adrenoceptor antagonist, markedly reduced the maximal response produced by phenylephrine, an agonist with high intrinsic activity, with no significant shift in the concentration response curve in human saphenous vein, suggesting that there was little or no alpha-1 receptor reserve for phenylephrine. The sensitivity of alpha-1 versus alpha-2 adrenoceptor-mediated vasoconstrictor responses to nitroglycerin were compared in human and canine saphenous veins. In both species, nitroglycerin blocked the vasoconstrictor response produced by stimulation of alpha-2 adrenoceptors to the same degree.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是确定人隐静脉中存在的α肾上腺素能受体亚型,并确定是否像在犬隐静脉中所证实的那样,去氧肾上腺素存在大量受体储备。使用选择性α1和α2肾上腺素能受体激动剂及拮抗剂来确定在分离的人隐静脉中发现的α肾上腺素能受体亚型。选择性α1拮抗剂哌唑嗪使去氧肾上腺素(一种选择性α1激动剂)的浓度-反应曲线平行右移,最大反应无显著降低。选择性α2拮抗剂育亨宾使选择性α2激动剂B-HT 920的浓度-反应曲线平行右移,最大反应无降低。在人隐静脉中获得的哌唑嗪和育亨宾的pA2值与在犬隐静脉中获得的相应值非常接近。这些结果表明人隐静脉中同时存在α1和α2肾上腺素能受体。不可逆α1肾上腺素能受体拮抗剂酚苄明(10(-7) M)显著降低了具有高内在活性的激动剂去氧肾上腺素所产生的最大反应,在人隐静脉中浓度-反应曲线无显著移位,提示去氧肾上腺素几乎没有α1受体储备。在人和犬的隐静脉中比较了α1与α2肾上腺素能受体介导的血管收缩反应对硝酸甘油的敏感性。在这两个物种中,硝酸甘油同等程度地阻断了刺激α2肾上腺素能受体所产生的血管收缩反应。(摘要截短于250字)